Adrian Senderowicz
CIK 1616230 · Chief Medical Officer · last filed 2025-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$197.9K
Companies
4
Total Filings
32
Lifetime Open-Market Net
-$2.14M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBYI | Director | 27,000 | $7.33 | $197.9K | -$904.8K | 19 | 2025-06-17 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Chief Medical Officer | 15,884 | $33.99 | $539.9K | -$1.24M | 6 | 2020-05-13 |
| Dare Bioscience, Inc. (CERU) Delisted | SVP, Chief Medical Officer | — | — | — | $0 | 5 | 2017-01-09 |
| Ignyta, Inc. (RXDX) Delisted | Chief Medical Officer | — | $199.92 | — | $0 | 2 | 2015-01-09 |
Recent Filings · Page 4 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-09 | Ignyta, Inc. (RXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-11 | Ignyta, Inc. (RXDX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–32 of 32
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.